首页> 外国专利> CELLULAR IMMUNOTHERAPEUTIC AGENT COMPOSITION FOR PREVENTING OR TREATING KOREAN INTRACTABLE MULTIPLE MYELOMA, CONTAINING CANCER-TESTIS ANTIGEN, AND PREPARATION METHOD THEREFOR

CELLULAR IMMUNOTHERAPEUTIC AGENT COMPOSITION FOR PREVENTING OR TREATING KOREAN INTRACTABLE MULTIPLE MYELOMA, CONTAINING CANCER-TESTIS ANTIGEN, AND PREPARATION METHOD THEREFOR

机译:预防或治疗含可食道癌抗原的韩国难治性多发性骨髓瘤的细胞免疫治疗剂组合物及其制备方法

摘要

The present invention relates to a composition for treating or preventing, by cancer immunotherapy, Korean intractable multiple myeloma, containing a cancer-testis antigen. It is expected that a cellular immunotherapeutic agent composition for preventing or treating multiple myeloma, containing, as active ingredients, dendritic cells, having an antigen loaded thereon, and cancer-testis antigen-specific cytotoxic τ lymphocytes derived therefrom, is used so as to induce a strong tumor-specific cytotoxic immune response in cancer immunotherapy and, simultaneously, be useful as a cancer treatment vaccine, which is safe and has no side effects.
机译:本发明涉及通过癌症免疫疗法治疗或预防含有癌-睾丸抗原的韩国难治性多发性骨髓瘤的组合物。期望使用用于预防或治疗多发性骨髓瘤的细胞免疫治疗剂组合物,其以其上载有抗原的树突状细胞和由其衍生的癌-睾丸抗原特异性细胞毒性τ淋巴细胞作为活性成分来诱导。在癌症免疫治疗中具有很强的肿瘤特异性细胞毒性免疫应答,同时可用作安全且无副作用的癌症治疗疫苗。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号